Favipiravir use in children with COVID-19 and acute kidney injury: is it safe?

BACKGROUND: The rising number of infections due to Severe Acute Respiratory Syndrome Coronavirus-2 (popularly known as COVID-19) has brought to the fore new antiviral drugs as possible treatments, including favipiravir. However, there is currently no data regarding the safety of this drug in patient...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Pediatr Nephrol
Asıl Yazarlar: Ozsurekci, Yasemin, Oygar, Pembe Derin, Gürlevik, Sibel Laçinel, Kesici, Selman, Ozen, Seza, Kurt Sukur, Eda Didem, Gülhan, Bora, Topaloglu, Rezan, Bayrakci, Benan, Cengiz, Ali Bülent
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer Berlin Heidelberg 2021
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8140325/
https://ncbi.nlm.nih.gov/pubmed/34021797
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00467-021-05111-x
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller